Study Finds Low Nephrology Referral Rate for High-Risk CKD
Even patients at the highest risk for kidney failure had inadequate nephrology referral, a study found.
Even patients at the highest risk for kidney failure had inadequate nephrology referral, a study found.
Nirmatrelvir/ritonavir is not current recommended for patients with CKD stage 4 or 5, but low-dose regimens could avoid adverse events, according to the authors of a recent editorial.
Sugar-sweetened beverages are a frequently consumed ultra-processed food group.
Nutritional therapy is an essential part of CKD management.
A round up of studies suggests it is difficult to increase serum total 25-hydroxyvitamin D levels enough to effectively lower elevated parathyroid hormone (PTH) levels in overweight patients with chronic kidney disease.
The EMPA-KIDNEY study enrolled more than 6600 patients with CKD attributable to a wide range of underlying causes.
The CRL stated that the application for bardoxolone could not be approved in its current form due to a lack of data supporting claims of slowing kidney function loss and reducing kidney failure progression.
Affordability of SGLT2i may contribute to the low prescription rate in CKD.
In a study of patients with stage 4 chronic kidney disease and poorly controlled blood pressure, chlorthalidone significantly decreased systolic blood pressure compared with placebo.
ALLN-346 is an investigational, first-in-class, nonabsorbed, orally-administered enzyme that breaks down urate in the gastrointestinal tract.